
This episode features Johan Hari discussing the benefits and risks of new weight loss drugs, particularly Ozempic and Wegovy. Hari shares his personal experience with these medications, their effects on appetite, and the societal implications of their rising popularity.
Hari explains how he lost three stone in a year using these drugs, which significantly reduced his hunger. He discusses the extraordinary effectiveness of these medications in combating obesity, noting that they can lead to a 15-24% reduction in body weight.
However, he also raises concerns about the potential risks, including muscle loss, pancreatitis, and the possibility of increased suicidal thoughts. Hari emphasizes the importance of understanding the psychological impacts of these drugs, especially for those with eating disorders.
The conversation touches on the broader societal issues surrounding obesity, the food industry, and how these medications may affect our relationship with food and health. Hari argues that while these drugs can be life-saving for some, they also raise ethical questions about their accessibility and the potential for misuse.
Overall, the episode presents a nuanced view of weight loss drugs, balancing their potential benefits against significant health risks and societal consequences.
Johan Hari discusses the benefits and risks of weight loss drugs like Ozempic, sharing personal experiences and societal implications.

This episode stands out for the following: